Nicolas Widmer
Impact in
- Hematology top 1%
- Chronic Myeloid Leukemia Treatments
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 21
- Chronic Myeloid Leukemia Treatments 20
- Genetics 15
- Chronic Lymphocytic Leukemia Research 15
- Co-authors
- Laurent A. Décosterd (38 shared papers)Thierry Buclin (37 shared papers)Chantal Csajka (27 shared papers)Michel A. Duchosal (10 shared papers)Dominique Levêque (3 shared papers)Gareth J. Veal (3 shared papers)Christophe Bardin (3 shared papers)Angélo Paci (3 shared papers)
- Journals
- Therapeutic Drug Monitoring (4 papers)Journal of Chromatography B (4 papers)British Journal of Clinical Pharmacology (4 papers)Clinical Pharmacokinetics (4 papers)European Journal of Cancer (3 papers)
- Partner nations
- SwitzerlandFranceUnited States
In The Last Decade
Nicolas Widmer
72 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 140
- Hematology 788
- Genetics 491
- Gastroenterology 121
- Infectious Diseases 417
- Pharmacology 307
Countries citing papers authored by Nicolas Widmer
This map shows the geographic impact of Nicolas Widmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Widmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Widmer more than expected).
Fields of papers citing papers by Nicolas Widmer
This network shows the impact of papers produced by Nicolas Widmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Widmer. The network helps show where Nicolas Widmer may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicolas Widmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 315 | |
| 2 | 2014 | 243 | |
| 3 | 2014 | 212 | |
| 4 | 2009 | 182 | |
| 5 | 2010 | 180 | |
| 6 | 2006 | 155 | |
| 7 | 2012 | 132 | |
| 8 | 2010 | 101 | |
| 9 | 2008 | 98 | |
| 10 | 2020 | 82 | |
| 11 | 2014 | 76 | |
| 12 | 2005 | 74 | |
| 13 | 2012 | 72 | |
| 14 | 2014 | 68 | |
| 15 | 2004 | 53 | |
| 16 | 2008 | 51 | |
| 17 | 2014 | 50 | |
| 18 | 2020 | 50 | |
| 19 | 2010 | 50 | |
| 20 | 2012 | 47 |
About Nicolas Widmer
Nicolas Widmer is a scholar working on Hematology, Genetics, Molecular Biology, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 75 papers that have together received 3.1k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (20 papers), Chronic Lymphocytic Leukemia Research (15 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), HER2/EGFR in Cancer Research (6 papers), Pharmaceutical studies and practices (6 papers), Eosinophilic Disorders and Syndromes (5 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Gastrointestinal Tumor Research and Treatment (4 papers). The work is most often cited by research in Hematology (788 citations), Genetics (491 citations), Gastroenterology (121 citations), Infectious Diseases (417 citations) and Pharmacology (307 citations). Nicolas Widmer has collaborated with scholars based in Switzerland, France and United States. Frequent co-authors include Laurent A. Décosterd, Thierry Buclin, Chantal Csajka, Michel A. Duchosal, Dominique Levêque, Gareth J. Veal, Christophe Bardin, Angélo Paci, A. Astier and Étienne Chatelut. Their work appears in journals such as Therapeutic Drug Monitoring, Journal of Chromatography B, British Journal of Clinical Pharmacology, Clinical Pharmacokinetics and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.